Acquiring an existing med spa gives you immediate cash flow, an active patient database, and a licensed medical director on day one — but building from scratch lets you design the model, culture, and compliance structure exactly as you want it. Here's how to decide which path is right for you.
The medical spa industry is one of the most attractive segments in lower middle market healthcare services — a $10B+ U.S. market growing toward $15B by 2027, fueled by consumer demand for injectables, laser treatments, and body contouring. The market is also highly fragmented, with thousands of independent owner-operated locations that represent real acquisition opportunity for strategic buyers and roll-up platforms. But that fragmentation also means new entrants continue to open de novo locations every year. Whether you're a private equity-backed aesthetics platform, an entrepreneurial nurse practitioner, or a high-net-worth operator looking for a cash-flowing business, the buy vs. build decision in med spa hinges on several factors unique to this industry: state-specific corporate practice of medicine (CPOM) laws, provider dependency risk, equipment capital requirements, and the time it takes to build a loyal patient base. This analysis breaks down both paths with specificity so you can make the right call for your goals, capital, and timeline.
Find Med Spa Businesses to AcquireAcquiring an established med spa means purchasing an operating business with an active patient database, employed or contracted injectors, existing equipment, a licensed medical director, and — in the best cases — a membership program generating predictable recurring revenue. For buyers who want cash flow from day one, an acquisition is almost always the faster and lower-risk path in this industry, provided you conduct thorough due diligence on compliance structure, provider concentration, and deferred revenue liabilities.
Private equity-backed roll-up platforms executing an aesthetics consolidation strategy, entrepreneurial physicians or NPs with healthcare operational experience who want immediate cash flow, and strategic acquirers in dermatology or plastic surgery seeking to expand their service footprint into medical aesthetics without building a brand from zero.
Building a med spa from scratch — often called a de novo launch — gives operators full control over location selection, service mix, compliance structure, culture, and brand positioning. It eliminates the risk of inheriting deferred liabilities, aging equipment, or provider conflicts. However, de novo med spas face a 12–24 month patient acquisition ramp, significant upfront capital requirements, and the full weight of navigating state licensing and CPOM compliance with no existing infrastructure to lean on.
Experienced aesthetics operators, physicians, or NPs who want to build a specific brand vision, have identified an underserved market with no suitable acquisition target, or are launching a de novo as part of a broader platform strategy after acquiring their first location to prove the model.
For most buyers and investors evaluating the med spa space in 2024, acquiring an existing practice is the superior path — especially if the target has a membership program with 200+ active members, a team of employed providers rather than a sole-injector owner, and a clean compliance history. The 12–24 month ramp of a de novo startup, combined with intense local competition and the capital required to reach profitability, makes building from scratch a harder economic case in most markets. That said, building makes sense in specific scenarios: when no acquisition-grade target exists in your target market, when you have the capital and patience to execute a multi-year brand-building strategy, or when you're launching a second or third location after proving the model through acquisition. If you pursue the acquisition path, invest heavily in due diligence — particularly on provider dependency, CPOM compliance structure, and deferred revenue obligations — because those three factors determine whether you're buying a business or a liability.
Is there a qualified acquisition target in your target market with $300K+ EBITDA, 1,000+ active patients, and a provider team that isn't entirely dependent on the selling owner — and if so, can you underwrite the deal at a valuation multiple that makes sense given the transition risk?
Do you have the capital and risk tolerance to sustain 12–24 months of losses or minimal cash flow that a de novo med spa requires before reaching profitability, or do you need the business to be cash-flow positive within 6 months of your investment?
Have you mapped the CPOM laws in your target state and determined whether an acquisition can be structured cleanly — or whether a de novo build with a purpose-built MSA and medical entity structure is actually the lower-compliance-risk path?
What is your role in operations — if you are a licensed injector who plans to be the primary provider, a de novo may allow you to build around your own patient relationships, but if you are a non-clinical operator, an acquisition with an existing provider team is likely essential to generating revenue from day one?
Are you building a single-location cash flow asset or a platform with multiple locations — because if the goal is a roll-up strategy, acquiring your first location to prove the model is almost always faster and more fundable than launching de novo and then trying to raise growth capital before you have an operating track record?
Browse Med Spa Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Most acquisition-grade med spas generating $300K–$700K in EBITDA trade at 3.5x–6x EBITDA, putting total purchase prices in the $1.05M–$4.2M range. With SBA 7(a) financing, buyers typically inject 10–20% equity ($105K–$840K) and finance the remainder. Additional transaction costs — legal, due diligence, deal structuring — typically add $50K–$150K. Equipment condition and deferred revenue liabilities can significantly affect your true all-in cost post-close.
Most de novo med spas reach their first revenue within 3–6 months of opening, but consistent monthly profitability typically takes 12–18 months, and reaching $300K+ EBITDA — the threshold that makes a business acquisition-grade — usually requires 2–3 years of operation. Patient acquisition, provider recruitment, and local brand building are the three biggest bottlenecks that determine how fast a new location reaches scale.
Provider dependency is the single most common value-destruction risk in med spa acquisitions. When the selling owner is the primary or sole injector, and their personal relationships drive the majority of bookings, revenue can fall 30–60% within 90 days of the transition if the seller exits quickly. Before closing, conduct a thorough provider concentration analysis, structure meaningful seller transition agreements, and where possible, require management rollover equity for any owner who represents more than 20% of revenue.
Yes — med spas are SBA 7(a) eligible businesses, and SBA financing is commonly used for both acquisitions and de novo launches. For acquisitions, SBA lenders typically require 10–20% buyer equity and want to see at least 2–3 years of financial history, $300K+ in EBITDA, and a clean compliance record. For startups, SBA loans are harder to obtain without an operating history, and lenders often require stronger personal collateral or a larger equity injection. CPOM-compliant deal structure must also be clearly documented for lender approval.
CPOM laws vary significantly by state and restrict the ability of non-physicians to own or control a medical practice. In restrictive CPOM states, med spa acquisitions are typically structured using a management services agreement (MSA) that separates the medical entity — owned by a licensed physician or professional corporation — from the business management entity owned by the investor. Both acquisitions and de novo startups must be structured to comply with the applicable state's CPOM rules, and failure to do so creates significant regulatory and legal exposure. Engaging a healthcare attorney with state-specific CPOM expertise before closing or launching is essential.
Deferred revenue in a med spa represents the cash already collected for services not yet delivered — primarily pre-sold treatment packages and prepaid membership obligations. When you acquire a med spa, you inherit the obligation to deliver those services without receiving additional payment, which effectively reduces your net cash flow in the months following close. On a $1M revenue med spa, deferred revenue liabilities can range from $50K to $200K or more. Buyers should require a full reconciliation of outstanding package and membership balances during due diligence and factor this liability into the purchase price negotiation or deal structure.
More Med Spa Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers